GW & Wade’s Elevance Health ELV Stock Holding History

GW & Wade’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-956	Closed	-$274K	–	236
2019 Q1	$274K	Buy	+956	New	+$276K	0.03%	195

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

GW & Wade's ELV Position: Q2 2019 in Review

GW & Wade sold out of Elevance Health (ELV) in Q2 2019, closing a stake of 956 shares — an estimated $274K sold.

GW & Wade first reported a position in ELV in Q1 2019 and held it in 1 quarter. The position peaked at $274K in Q1 2019. 1,030 funds tracked by Wall St. Rank hold ELV as of Q2 2019.

GW & Wade reported no remaining Elevance Health position as of Q2 2019 after selling out during the quarter.
GW & Wade sold 956 Elevance Health shares in Q2 2019, an estimated $274K.
GW & Wade first reported a position in Elevance Health in Q1 2019 and held it in 1 quarter.
GW & Wade's Elevance Health position peaked at $274K in Q1 2019.
1,030 funds tracked by Wall St. Rank held Elevance Health as of Q2 2019.

Based on GW & Wade's 13F filing for Q2 2019, filed 12 Aug 2019.